Protean Biodiagnostics
Orlando, US · Founded 2017 · Florida corporation
Protean BioDiagnostics offers Protean MAPS, a cancer profiling and diagnostics platform that combines oncology tests with decision-support tools, telemedicine, virtual tumor boards, and AI-based clinical trial matching. It serves oncologists seeking precision oncology guidance across all cancer types.
Founders & leadership
Protean Biodiagnostics was founded in 2017 by Anthony M. Magliocco.
AM
Anthony M. MaglioccoinFounder
Board
FM
Frank MorsaniBoard director
AC
Anees ChagparBoard director
Reported raises · per SEC filings
Form D private placements$1.8M disclosed across 2 of 4 rounds · 2019–2023
▶$6MofferedDec 2023 · Other Health CareRule 506(b)
▶$6MofferedDec 2023 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ronen IsraelDirector
- Frank MorsaniDirector
- Susan LeeExecutive Officer
- Anees ChagparDirector
- Violet JamesonDirector
- Anthony Martin MaglioccoExecutive Officer, Director
- Offering amount
- $6M
- Minimum investment
- $50K
- Sales commissions
- $360K
- Proceeds to insiders
- $250K
- Placement agents
- Tangent Capital Partners, LLC
- Incorporated
- Corporation, Florida
- Federal exemptions
- 06b
▶$1.4MraisedMay 2021 · 12 investors · Other Health CareRule 506(b)
▶$1.4MraisedMay 2021 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Anees ChagparDirector
- Frank MorsaniDirector
- Anthony M. MaglioccoExecutive Officer, Director, Promoter
- Offering amount
- $1.7M
- Amount sold
- $1.4M
- Minimum investment
- $30K
- Incorporated
- Corporation, Florida, 2017
- Federal exemptions
- 06b
▶$1.5MofferedMay 2021 · Other Health CareRule 506(b)
▶$1.5MofferedMay 2021 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Frank MorsaniDirector
- Anthony M. MaglioccoExecutive Officer, Director, Promoter
- Anees ChagparDirector
- Offering amount
- $1.5M
- Minimum investment
- $30K
- Placement agents
- Eastgate Securities, LLC
- Incorporated
- Corporation, Florida, 2017
- Federal exemptions
- 06b
▶$330KraisedJun 2019 · 4 investors · Other Health CareRule 506(b)
▶$330KraisedJun 2019 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Frank MorsaniDirector
- Anthony M. MaglioccoExecutive Officer, Director, Promoter
- Anees ChagparDirector
- Offering amount
- $800K
- Amount sold
- $330K
- First sale
- Jun 2019
- Incorporated
- Corporation, Florida, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapLabcorp8 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Cancerresearchuk7 shared keywordsCancer Research UK funds research across discovery, detection, prevention and treatment of cancer to improve patient outcomes and extend survival. It operates as a research funder and scientific organization serving academic and clinical researchers.
MD Anderson Cancer Center7 shared keywordsUT MD Anderson is a cancer research and treatment center that provides patient care, conducts research, and offers education in cancer prevention and treatment. It is part of the University of Texas System and operates as a nonprofit medical institution.
Companies competing with Protean Biodiagnostics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Protean Biodiagnostics do?
- Protean BioDiagnostics offers Protean MAPS, a cancer profiling and diagnostics platform that combines oncology tests with decision-support tools, telemedicine, virtual tumor boards, and AI-based clinical trial matching. It serves oncologists seeking precision oncology guidance across all cancer types.
- Who founded Protean Biodiagnostics?
- Protean Biodiagnostics was founded by Anthony M. Magliocco in 2017.
- How much funding has Protean Biodiagnostics raised?
- Protean Biodiagnostics has disclosed $1.8M raised across 2 of its 4 known rounds.
- Where is Protean Biodiagnostics headquartered?
- Protean Biodiagnostics is headquartered in Orlando, US.